...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Clinical Features of Multiple Primary Malignancies: a Retrospective Analysis of 72 Chinese Patients
【24h】

Clinical Features of Multiple Primary Malignancies: a Retrospective Analysis of 72 Chinese Patients

机译:多发性恶性肿瘤的临床特征:72例中国患者的回顾性分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

There is a scarcity of reports addressing patients with multiple primary malignancies (MPM), especially for Chinese cses. The aim of this study was to present a detailed analysis of Chinese patients presenting with at least two primary malignancies. Particularly, the clinical characteristics and survival between synchronous and metachronous MPM were compared. Out of 6,545 cases, 72 patients (1.1%) including 39 males (54.2%) and 33 females (45.8%) were diagnosed as MPM, giving a male: female sex ratio of 1.2:1. Of these, there were 16 (22.2%) cases of synchronous MPM (7 males, 9 females), 55(76.4%) metachronous (31 males, 24 females), and 1 "mixed form". For first tumor diagnosis time, synchronous MPM patients generally presented later than the metachronous cases. The top three sites for malignancies with metachronous MPM were colorectum, head and neck, and lung, while for synchronous they were lung, colorectum and breast. Among MPM patients, the median survival time was 15.7 years and the 5-year survival was 56%, and there was statistical difference in MPM categories (P 0.05). The median survival time was 17.3 years and 3.8 years for metachronous and synchronous MPM patients, respectively. In comparison with synchronous MPM patients, those metachronous had a longer survival. This studies increase understanding of the clinical features of Chinese MPM patients and suggest that those presenting with metachronous cancers have a higher incidence and a better prognosis.
机译:报告缺乏发表患有多个原发性恶性肿瘤(MPM)的患者,特别是对于中国CSE。本研究的目的是对患有至少两次原发性恶性肿瘤的中国患者进行详细分析。特别地,比较了同步和同学MPM之间的临床特征和生存。在6,545例患者中,72名患者(1.1%),包括39名男性(54.2%)和33名女性(45.8%)被诊断为MPM,给予男性:女性性别比为1.2:1。其中,有16例(22.2%)同步MPM(7个男性,9名女性),55(76.4%)同学(31个男性,24名女性)和1个“混合形式”。对于先进的肿瘤诊断时间,同步MPM患者通常比同等偶然呈现。具有同学MPM的恶性肿瘤的前三个地点是结肠肠,头部和颈部,肺部,同时同步它们是肺,结肠肠和乳房。在MPM患者中,中位生存时间为15.7岁,5年生存率为56%,MPM类别统计学差异(P <0.05)。中位生存时间分别为同学和同步MPM患者的17.3岁至3年。与同步MPM患者相比,那些同学的存活率更长。这项研究提高了对中国MPM患者的临床特征的理解,并提出了具有比较癌症的人具有更高的发病率和更好的预后。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号